A Study to Investigate the Plasma Concentration of YM150 After Repeated Administration to Elderly Subjects

Clinical trial NCT01514825 · COMPLETED

Trial details

NCT number: NCT01514825
Sponsor: Astellas Pharma Inc
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Elderly Subject Pharmacokinetic of YM150

Start date: 2006-11-01
Primary completion: 2007-02-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.